LiveLive
SPX7,652.86-1.1900%IXIC25,980.19-2.4900%FTSE10,854.321.2500%GOLD4,668.800.5600%SILVER69.530.6400%PLATINUM1,890.000.3700%PALLADIUM1,389.000.8700%BRENT92.130.5600%DJI53,417.16-0.0800%WTI85.19-0.7500%NDX29,023.18-3.2400%NATGAS2.80-0.3900%BTC78,906.001.5100%RUT2,995.08-2.0400%VIX15.850.0600%ETH2,482.940.7900%DAX26,106.60-0.8800%BNB701.43-0.1600%XRP1.48-2.7200%CAC408,453.01-0.6600%NKY65,528.090.3100%DOGE0.09-3.6900%HSI25,517.330.2500%ADA0.22-2.3500%NIFTY24,219.050.2700%SOL98.873.6000%AAPL310.341.5500%SENSEX77,369.110.1700%MSFT487.311.4500%TASI11,174.130.8600%IBOV171,906.723.0700%GOOGL348.061.1800%TSLA348.952.8400%MERVAL2,995,129.503.5800%TSX36,714.120.1300%USD/PKR277.280.4000%ASX2009,103.100.3600%EUR/PKR323.551.2200%STI5,680.46-1.5300%GBP/PKR378.191.1100%SAR/PKR73.85-0.0200%FBMKLCI1,736.330.1700%AED/PKR75.500.0000%SET1,601.05-0.7900%KOSPI6,696.96-4.0300%USD/EUR0.86-0.7600%TWSE44,762.32-1.2100%GASOLINE2.98-8.4700%HEATOIL4.19-5.8900%COPPER6.622.0500%WHEAT700.502.9800%CORN515.508.9900%SOYBEANS1,225.500.2700%COFFEE341.80-4.9200%COCOA5,929.00-1.9400%SUGAR17.660.6300%COTTON88.011.1600%TRX0.340.2400%AVAX7.54-0.7700%LINK11.620.7200%DOT0.90-3.1100%LTC51.64-1.3600%SHIB0.00-1.4400%TON1.46-2.0500%XLM0.19-3.6900%HBAR0.080.0800%SUI0.80-5.9900%APT0.61-4.8000%UNI4.33-4.2900%PEPE0.00-1.2300%NEAR1.95-3.1400%ARB0.10-4.2100%OP0.11-3.7600%MATIC0.130.0000%INJ5.696.1800%FIL0.75-2.6200%ICP2.42-0.3600%STX0.000.0000%ETC7.76-2.5200%ALGO0.09-2.2900%VET0.01-2.0200%THETA0.18-2.9100%FTM0.0327.1200%SAND0.04-7.4100%MANA0.07-2.3800%AXS0.97-4.1800%GALA0.00-1.2200%CRV0.342.9500%MKR1,567.82-1.9600%AMZN262.070.2900%NVDA208.48-7.3500%META559.02-1.7500%NFLX80.015.2500%AMD456.75-9.7300%AVGO358.76-8.5800%JPM356.39-1.2700%V382.416.5700%MA599.866.6900%XOM164.051.6000%CVX203.090.1900%KO91.995.7600%PEP144.674.6500%DIS110.616.8700%BA210.46-6.8600%BABA118.47-5.0000%JD29.202.4600%PDD87.070.1500%NIO4.36-5.2200%SPY763.47-1.1900%QQQ706.32-3.2300%DIA533.65-0.1000%IWM297.97-2.0000%GLD426.695.2300%SLV62.204.4100%TLT82.561.4900%HYG79.700.1100%LQD106.180.4500%XLF58.221.1100%XLK180.05-5.4000%XLE63.110.8500%XLV174.704.5800%SMH546.80-7.9600%ARKK83.922.6500%EEM66.11-1.8000%IBIT44.6422.5700%QAR/PKR76.17-0.1400%INR/PKR2.89-0.4300%JPY/PKR1.740.1600%CAD/PKR200.350.6200%AUD/PKR198.281.3300%NZD/PKR165.401.7800%MYR/PKR68.631.1000%THB/PKR8.481.6600%EUR/USD1.170.7800%GBP/USD1.360.7200%USD/JPY159.10-0.2800%USD/CHF0.80-1.2100%AUD/USD0.720.6300%USD/CAD1.38-0.3900%NZD/USD0.600.9500%USD/INR95.73-0.0800%USD/CNY6.71-0.4500%USD/HKD7.84-0.1000%USD/SGD1.27-0.6300%USD/KRW1,381.80-2.3300%USD/TRY48.070.3500%USD/ZAR16.02-1.4300%USD/MXN16.95-0.4800%USD/BRL5.16-1.1000%USD/RUB83.39-1.8300%USD/NGN1,344.56-0.3700%USD/EGP50.770.5500%USD/KES129.400.7900%USD/BDT122.621.7900%USD/LKR329.002.0100%USD/IDR17,698.00-0.4000%USD/THB32.70-0.9100%USD/MYR4.04-0.4300%USD/PHP61.681.1700%USD/VND26,172.00-0.0100%USD/ILS3.000.1200%USD/SAR3.753.3400%USD/AED3.670.0300%USD/QAR3.64-0.1400%USD/KWD0.31-0.1300%USD/BHD0.383.0300%USD/OMR0.390.4700%SPX7,652.86-1.1900%IXIC25,980.19-2.4900%FTSE10,854.321.2500%GOLD4,668.800.5600%SILVER69.530.6400%PLATINUM1,890.000.3700%PALLADIUM1,389.000.8700%BRENT92.130.5600%DJI53,417.16-0.0800%WTI85.19-0.7500%NDX29,023.18-3.2400%NATGAS2.80-0.3900%BTC78,906.001.5100%RUT2,995.08-2.0400%VIX15.850.0600%ETH2,482.940.7900%DAX26,106.60-0.8800%BNB701.43-0.1600%XRP1.48-2.7200%CAC408,453.01-0.6600%NKY65,528.090.3100%DOGE0.09-3.6900%HSI25,517.330.2500%ADA0.22-2.3500%NIFTY24,219.050.2700%SOL98.873.6000%AAPL310.341.5500%SENSEX77,369.110.1700%MSFT487.311.4500%TASI11,174.130.8600%IBOV171,906.723.0700%GOOGL348.061.1800%TSLA348.952.8400%MERVAL2,995,129.503.5800%TSX36,714.120.1300%USD/PKR277.280.4000%ASX2009,103.100.3600%EUR/PKR323.551.2200%STI5,680.46-1.5300%GBP/PKR378.191.1100%SAR/PKR73.85-0.0200%FBMKLCI1,736.330.1700%AED/PKR75.500.0000%SET1,601.05-0.7900%KOSPI6,696.96-4.0300%USD/EUR0.86-0.7600%TWSE44,762.32-1.2100%GASOLINE2.98-8.4700%HEATOIL4.19-5.8900%COPPER6.622.0500%WHEAT700.502.9800%CORN515.508.9900%SOYBEANS1,225.500.2700%COFFEE341.80-4.9200%COCOA5,929.00-1.9400%SUGAR17.660.6300%COTTON88.011.1600%TRX0.340.2400%AVAX7.54-0.7700%LINK11.620.7200%DOT0.90-3.1100%LTC51.64-1.3600%SHIB0.00-1.4400%TON1.46-2.0500%XLM0.19-3.6900%HBAR0.080.0800%SUI0.80-5.9900%APT0.61-4.8000%UNI4.33-4.2900%PEPE0.00-1.2300%NEAR1.95-3.1400%ARB0.10-4.2100%OP0.11-3.7600%MATIC0.130.0000%INJ5.696.1800%FIL0.75-2.6200%ICP2.42-0.3600%STX0.000.0000%ETC7.76-2.5200%ALGO0.09-2.2900%VET0.01-2.0200%THETA0.18-2.9100%FTM0.0327.1200%SAND0.04-7.4100%MANA0.07-2.3800%AXS0.97-4.1800%GALA0.00-1.2200%CRV0.342.9500%MKR1,567.82-1.9600%AMZN262.070.2900%NVDA208.48-7.3500%META559.02-1.7500%NFLX80.015.2500%AMD456.75-9.7300%AVGO358.76-8.5800%JPM356.39-1.2700%V382.416.5700%MA599.866.6900%XOM164.051.6000%CVX203.090.1900%KO91.995.7600%PEP144.674.6500%DIS110.616.8700%BA210.46-6.8600%BABA118.47-5.0000%JD29.202.4600%PDD87.070.1500%NIO4.36-5.2200%SPY763.47-1.1900%QQQ706.32-3.2300%DIA533.65-0.1000%IWM297.97-2.0000%GLD426.695.2300%SLV62.204.4100%TLT82.561.4900%HYG79.700.1100%LQD106.180.4500%XLF58.221.1100%XLK180.05-5.4000%XLE63.110.8500%XLV174.704.5800%SMH546.80-7.9600%ARKK83.922.6500%EEM66.11-1.8000%IBIT44.6422.5700%QAR/PKR76.17-0.1400%INR/PKR2.89-0.4300%JPY/PKR1.740.1600%CAD/PKR200.350.6200%AUD/PKR198.281.3300%NZD/PKR165.401.7800%MYR/PKR68.631.1000%THB/PKR8.481.6600%EUR/USD1.170.7800%GBP/USD1.360.7200%USD/JPY159.10-0.2800%USD/CHF0.80-1.2100%AUD/USD0.720.6300%USD/CAD1.38-0.3900%NZD/USD0.600.9500%USD/INR95.73-0.0800%USD/CNY6.71-0.4500%USD/HKD7.84-0.1000%USD/SGD1.27-0.6300%USD/KRW1,381.80-2.3300%USD/TRY48.070.3500%USD/ZAR16.02-1.4300%USD/MXN16.95-0.4800%USD/BRL5.16-1.1000%USD/RUB83.39-1.8300%USD/NGN1,344.56-0.3700%USD/EGP50.770.5500%USD/KES129.400.7900%USD/BDT122.621.7900%USD/LKR329.002.0100%USD/IDR17,698.00-0.4000%USD/THB32.70-0.9100%USD/MYR4.04-0.4300%USD/PHP61.681.1700%USD/VND26,172.00-0.0100%USD/ILS3.000.1200%USD/SAR3.753.3400%USD/AED3.670.0300%USD/QAR3.64-0.1400%USD/KWD0.31-0.1300%USD/BHD0.383.0300%USD/OMR0.390.4700%
Tuesday, 25 August 2026
GuruAlpha
Paper Companies and Poison Pills: Inside the Billions Siphoned from Umerkot Health Budget
World

Paper Companies and Poison Pills: Inside the Billions Siphoned from Umerkot Health Budget

An investigation into Umerkot’s Health Department reveals billions siphoned through ghost contractors, leaving vulnerable patients with ineffective, substandard drugs.

GA

GuruAlpha News Desk

GuruAlpha News Desk

4 min read
ShareXFacebookWhatsApp

An investigation into the Health Department of Umerkot district in Sindh has unveiled billions of rupees in public funds allegedly embezzled through phantom contractors and ghost suppliers. Official procurement records show a network of paper companies securing lucrative government medical contracts, culminating in the widespread distribution of substandard medicines across public healthcare facilities in August 2026.

The scale of the financial drain hits a region already grappling with extreme poverty, acute child malnutrition, and seasonal outbreaks of waterborne infectious diseases. Rather than strengthening the fragile medical safety net of the Thar desert border, state funds vanished into bank accounts registered to nonexistent office addresses and fraudulent tax numbers.

The Anatomy of Ghost Contracts: How Paper Firms Drained District Coffers

The operational blueprint of the Umerkot health scam relied on bypassing competitive bidding rules established under the Sindh Public Procurement Regulatory Authority (SPPRA). Procurement officers routinely approved multi-million-rupee purchase orders for life-saving drugs, surgical equipment, and hospital consumables, directing them toward newly minted entities that existed solely on paper.

Audit documentation reveals that several winning vendors shared identical postal addresses, registration details, and banking signatories. In multiple instances, contracts were split into smaller tranches to evade formal oversight by provincial procurement boards. These ghost companies collected full payments from the treasury for medical inventory that was either delivered in negligible quantities or never produced at all.

Local whistleblower reports initially alerted provincial anti-corruption authorities after routine deliveries of essential supplies to basic health units (BHUs) across Umerkot, Pithoro, and Samaro suddenly ceased, despite budget ledgers marking the allocations as fully disbursed. Financial forensic teams analyzing the disbursements discovered millions transferred directly to personal accounts associated with local health administrators and their close associates.

Spurious Supplies: Trading Human Lives for Kickbacks

Where physical goods did arrive at public dispensaries and district headquarter hospitals, medical staff encountered dangerous discrepancies. Procurement records show orders placed for premium-grade pharmaceuticals from certified manufacturers, yet the stock rooms received cheap, unverified formulations lacking regulatory approval from the Drug Regulatory Authority of Pakistan (DRAP).

Distributors funneled compromised antibiotics, degraded saline fluids, and ineffective antipyretics into public wards. Laboratory screening of sample batches recovered from government storage facilities in Umerkot confirmed severe potency deficits and contamination risks. In a district where thousands of low-income families rely exclusively on state-run clinics for emergency care, patients were administered inert or contaminated treatments for critical conditions.

Healthcare providers working inside Umerkot’s main facilities reported unprecedented treatment failures during peak summer admissions. Doctors routinely instructed patients' families to purchase basic medicines from private pharmacies outside municipal hospitals because government-supplied stocks failed to yield basic therapeutic results. The practice effectively forced impoverished citizens to pay out-of-pocket for life-saving drugs after public coffers had already been cleared under the guise of providing free healthcare.

Institutional Decay in Rural Sindh’s Healthcare Network

The Umerkot embezzlement scheme reflects a deeper systemic vulnerability across rural healthcare administration in Sindh. Historically, district health offices manage substantial discretionary operational budgets with minimal real-time digital tracking. Decentralized purchasing mechanisms, intended to accelerate emergency procurement during health crises, frequently transform into unmonitored channels for financial diversion.

This systemic breakdown carries devastating consequences for regional health indicators. Umerkot registers some of the highest maternal and infant mortality ratios in lower Sindh, worsened by recurring heatwaves and severe drought conditions in surrounding rural union councils. When billions meant for pediatric care, snakebite antivenoms, and maternal survival kits are diverted into shell companies, public health infrastructure collapses at its most critical juncture.

Anti-corruption agencies and provincial audit teams have initiated formal inquiries to freeze contested accounts, recover diverted state funds, and hold implicated health officials and private conspirators criminally accountable. Restoring integrity to the district's public health delivery demands immediate digitization of procurement ledgers, rigorous batch testing of delivered medical supplies, and independent oversight of vendor qualification processes.

Frequently Asked Questions

What specific illegal tactics were used in the Umerkot Health Department scandal?

Officials awarded contracts to paper firms sharing identical registration details to bypass procurement rules. Payments were fully disbursed for medical supplies that were either missing or replaced with unverified, low-potency drugs.

How did substandard medicines impact patients visiting public hospitals in Umerkot?

Patients received compromised antibiotics and antipyretics that failed to treat illnesses, forcing doctors to send poor families to private pharmacies to purchase essential life-saving drugs.

What actions have oversight authorities taken regarding the illegal contracts?

Provincial audit teams and anti-corruption agencies have initiated inquiries to trace siphoned funds, freeze associated vendor bank accounts, and prosecute implicated health officials and fake vendors.

Source:express.pk
Share this story
ShareXFacebookWhatsApp
GA

GuruAlpha News Desk

The GuruAlpha News team delivers accurate, timely coverage of breaking news, markets, technology, and lifestyle — in English and Urdu.

NewsBreaking

Related Stories

All World

More Stories

Home

What is GuruAlpha?

GuruAlpha is a comprehensive digital platform offering live financial markets, free calculators, online tools, Islamic content, SIM packages, sports updates and celebrity profiles for Pakistan, Gulf countries and worldwide audiences.

Is GuruAlpha free to use?

Yes, GuruAlpha is completely free. All calculators, tools, market data, prayer times, Islamic resources and content are available without any subscription or sign-up.

Does GuruAlpha provide live market data?

Yes, GuruAlpha provides live market data including USD/PKR exchange rates, gold prices, cryptocurrency prices, stock market indices and commodity prices sourced from reliable financial data providers.

What calculators are available on GuruAlpha?

GuruAlpha offers over 1,200 calculators including Pakistan income tax, salary tax, PTA mobile tax, electricity bill, gold price, currency converter, Zakat calculator, property tax and many more.

Does GuruAlpha have Islamic prayer times?

Yes, GuruAlpha provides accurate prayer times for over 100 cities worldwide including Fajr, Dhuhr, Asr, Maghrib and Isha times. We also offer Qibla direction, Islamic calendar and Zakat calculator.